Profound Medical Corp. (PROF) Dividend History

Company News

• High Intensity Focused Ultrasound (HIFU) Market to Reach $1.81 Billion by 2034, Growing at a CAGR of 10.4% | Rising Demand for Non-Invasive Therapeutic Solutions Driving Global Market Expansion

  The global HIFU market is expected to grow rapidly over the next decade, driven by the rising demand for non-invasive therapeutic solutions and advancements in imaging technology. Key growth regions include Asia-Pacific and North America.

  GlobeNewswire Inc.
• Profound Medical Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Revenues

  Profound Medical reported strong preliminary Q4 2024 revenue growth of 105-110% year-over-year, driven by increased adoption of its TULSA-PRO technology. The company will transition to reporting under U.S. GAAP and filing with the SEC on domestic forms to better serve its primarily U.S.-based investor base.

  Benzinga
• Profound Medical (PROF) Adds AI to Prostate Cancer Treatment

  Profound Medical's (PROF) Contouring Assistant integrates AI into prostate cancer procedures, thereby streamlining the treatment planning process and enhancing both efficiency and precision.

  Zacks Investment Research

  Featured Companies: ALGN DVA MEDP
• Profound Medical Corp. (PROF) Q2 2022 Earnings Call Transcript

  PROF earnings call for the period ending June 30, 2022.

  The Motley Fool
• The Anatomy Of My High-Growth Portfolio

  I operate two main portfolios: my safe portfolio and my high growth portfolio. This article will dissect and focus on my high-growth holdings.

  Seeking Alpha

  Featured Companies: ABCL ADPT AI AMRC AMZN ARRY ASTS BEAM CHPT CRSP CRWD CYBR DDOG DT EDIT ENPH ESTC FSLR GOOG GOOGL HASI LILA LILAK MELI MP MSFT NFLX NTLA NVDA OKTA PACB PATH PLTR QS RLAY ROCK SAIL SDGR SEDG SNOW SPCE TLS TTD TWST U Z ZG ZS